Titan Pharmaceuticals
TTNP
#9891
Rank
A$5.78 M
Marketcap
$6.33
Share price
-0.24%
Change (1 day)
-50.87%
Change (1 year)

P/E ratio for Titan Pharmaceuticals (TTNP)

P/E ratio as of November 2024 (TTM): -7.32

According to Titan Pharmaceuticals 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -7.31579. At the end of 2022 the company had a P/E ratio of -20.3.

P/E ratio history for Titan Pharmaceuticals from 2001 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-20.3-10.62%
2021-22.787.47%
2020-12.1208.22%
2019-3.92-71.78%
2018-13.9-64.72%
2017-39.4-112.73%
2016310-291.77%
2015-161-53.94%
2014-351-466.65%
201395.6-203.83%
2012-92.14.53%
2011-88.1-63.15%
2010-239-48.48%
2009-464
2007-82.3-48.16%
2006-159281.42%
2005-41.6-46.58%
2004-77.942.16%
2003-54.892.75%
2002-28.4-90.91%
2001-313

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
19.0-359.20%๐Ÿ‡บ๐Ÿ‡ธ USA
-6.16-15.80%๐Ÿ‡บ๐Ÿ‡ธ USA
-10.9 49.39%๐Ÿ‡บ๐Ÿ‡ธ USA
11.1-251.43%๐Ÿ‡บ๐Ÿ‡ธ USA
28.4-488.80%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
67.8-1,026.29%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.